Claglid Met 60mg/500mg Tablet
By Claglid Met
Rx
10 Tablet in a Strip

Composition
Gliclazide(60mg) + Metformin(500mg)

Manufacturer - Proqol Healthcare
Proqol Healthcare Pvt. Ltd., No 6 , Shop No 5, 2nd Floor, Sneham Commercial complex, MTH Road, Padi, Chennai- 600050

Expires on or after
September, 2025

liver
When it comes to your liver health and taking Claglid Met 60mg/500mg Tablet, caution is advised. If you have a liver disease, it is important to be careful when using this medication. Your doctor may need to adjust the dose of Claglid Met 60mg/500mg Tablet for you. Typically, the treatment begins with a low dose for individuals with mild to moderate liver disease. However, it is not recommended to use this medication if you have severe liver disease. It is crucial to consult your doctor for personalized guidance regarding the use of Claglid Met 60mg/500mg Tablet in relation to your liver condition.

kidney
Caution is advised for patients with kidney disease when using Claglid Met 60mg/500mg Tablet. Dose adjustment may be required. Not recommended for severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor.

alcohol
It is not safe to drink alcohol while taking Claglid Met 60mg/500mg Tablet.

driving
If your blood sugar is too low or too high, driving ability may be affected. Avoid driving if experiencing these symptoms with Claglid Met 60mg/500mg Tablet.

pregnancy
Claglid Met 60mg/500mg Tablet is not safe during pregnancy due to potential risks to the baby. However, in life-threatening situations, a doctor may prescribe it if benefits exceed risks. Consult your doctor before use.

breastfeeding
Caution is advised when breastfeeding while using Claglid Met 60mg/500mg Tablet, as it may potentially harm the baby by passing into the breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹106.4
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024